The role of chemoradiotherapy in maintaining quality of life for advanced esophageal cancer

American Journal of Hospice and Palliative Medicine

Volumn 15, Issue 1, 1998, Pages 29-31

  Tan, Robert ^a   Young, Andrew ^b  

^a MIN SHENG GENERAL HOSPITAL   (Taiwan)

^b TAO YUAN GENERAL HOSPITAL   (Taiwan)

Author keywords

Concurrent chemoradiotherapy; Esophageal cancer; Qualify of life

Indexed keywords

ANTIDOTE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; AGED; ARTICLE; ESOPHAGUS TUMOR; HUMAN; MALE; PALLIATIVE THERAPY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE;

AGED; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; PALLIATIVE CARE; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT;

EID: 0031602177     PISSN: 10499091     EISSN: None     Source Type: Journal    
DOI: 10.1177/104990919801500107     Document Type: Article

References (25)

1. Byfield J, Barone R, Mendelsohn J, et al: Infusional 5-fluorouracil and x-ray therapy for non-resectable esophageal cancer. Cancer. 1980;45:703.
2. Earle J, Gelber R, Moertel C, et al: A controlled evaluation of combined radiation and bleomycin therapy for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 1980;6:821.
3. Steiger Z, Franklin R, Wilson RF, et al: Complete eradication of squamous cell carcinoma of the esophagus with combined chemotherapy and radiotherapy. Am Surg. 1981;47:95.
4. Nigro ND, Vaitkevicus VK, Considene B: Combined therapy for cancer of the anal canal: A preliminary report. Dis Colon Rectum. 1977;20:677.
5. Franklin R, Steiger Z, Vaishampayan G, et al: Combined therapy for esophageal squamous cell carcinoma. Cancer. 1983;51:1062.
6. Steiger Z, Franklin R, Wilson RF, et al: Eradication and palliation of squamous cell carcinoma of the esophagus with chemotherapy, radiotherapy and surgical therapy. J Thoracic Cardiovasc Surg. 1981;82:713.
7. Chan A, Wong A, Arthur K: Continuous 5-fluorouracil infusion, mitomycin c and radical radiation therapy in esophageal squamous cell carcinoma. Int J Radiat Oncolo Biol Phys. 1989;16:59.
8. John M, Flam M, Mowry P, et al: Radiotherapy alone and chemoradiation for non-metastatic esophageal carcinoma: a critical review of chemoradiation. Cancer. 1989;63:2397.
9. Keane T, Howard A, Elhakim T, et al: Radical radiation therapy with 5-fluorouracil infusion and mitomycin c for esophageal squamous cell carcinoma. Radiother Oncol. 1875;4:205.
10. Leichman L, Herskovic A, Leichman CG, et al: Nonoperative therapy for squamous cell cancer of the esophagus. J Clin Oncol. 1987;5:365.
11. Herskovic A, Leichman L, Lattin P, et al: Chemoradiation with and without surgery in the thoracic esophagus: the Wayne State experience. Int J Radiat Oncol Biol Phys. 1988;15:655.
12. Richmond J, Seydel HG, Bae Y, et al: Comparison of three treatment strategies for esophageal cancer within a single institution. Int J Radiat Oncol Biol Phys. 1987;13:1617.
13. Seitz J, Giovanninni M, Pdaut-Cesana J, et al: Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy. Cancer. 1990;66:214.
14. Araujo C, Souhami L, Gil R, et al: A randomized trial comparing radiation therapy versus concomitant radiation therapy and chemotherapy in carcinoma of the thoracic esophagus. Cancer. 1991;67:2258.
15. Herskovic A, Martz K, Al-Sarraf M, et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992;326:1593.
16. Roussel A, Bleiberg H, Dalesio O, et al: Palliative therapy of inoperable esophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial. Int J Radiat Oncol Biol Phys. 1989;16:67.
17. Sischy B, Ryan L, Haller D, et al: Interim report of EST 1282 Phase III protocol for the evaluation of combined modalities in the treatment of patients with carcinoma of the esophagus stage I and II. Proc Am Soc Clin Oncol. 1990;9:105.
18. Coia L, Engstrom P, Paul A, et al: Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys. 1991;20:29.
19. Orringer MB: Substernal bypass of the excluded esophagus; results of an ill-advised operation. Surgery. 1984;96:467.
20. Coonley CJ, Bains M, Hilaris B, et al: Cisplatin and Bleomycin in the treatment of esophageal carcinoma: a final report. Cancer. 1984;54:2351.
21. Kelsen D, Hilaris B, Coonley C, et al: Cisplatin, vindesine and bleomycin chemotherapy of local regional and advanced esophageal carcinoma. Am J Med. 1983;75:645.
22. Kelsen DP, Fein R, Coonley C, et al: Cisplatin, vindesine and mitoguazone in the treatment of esophageal cancer. Cancer Treat Rep. 1986;70:255.
23. Lovett D, Kelsen D, Eisenberger M, et al: A phase II trial of carbo-platin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus. Cancer. 1991;67:354.
24. Kelsen D, Lovett D, Wong J, et al: Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal carcinoma. J Clin Oncol. 1992;10:269.
25. Ilson DH, Sirott M, Saltz L, et al: A phase II trial of interferon alfa-2a, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma. Cancer. 1995;74:2197.